Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of remimazolam on serum inflammatory markers of diabetic patients under general anesthesia
KCT0008909Phase 4Completed
- Sponsor
- Korea University Ansan Hospital
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam in type 2 diabetes mellitus (T2DM), sponsored by Korea University Ansan Hospital. Started Jul 2022; status: completed.
02
Drugs
remimazolam
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on KCT0008909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008909.